← All science articles

· 2 min read

Yeast Enzyme Shown to Cut DNA Precisely at RNA-DNA Junctions

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

Karwan and Wintersberger, writing in FEBS Letters in 1986, describe how a yeast enzyme cuts a hybrid molecule made of RNA and DNA at a very specific point. This is a laboratory biochemistry study, not a medical or skin study.

The researchers built a synthetic test molecule — a strand of M13 viral DNA paired with a stretch of RNA joined to radioactively labeled DNA — to see exactly how an enzyme called RNase H(70), isolated from the yeast Saccharomyces cerevisiae, breaks down such mixed molecules. RNase H enzymes normally degrade RNA when it is paired with DNA, a key step in processes like DNA replication.

The study found that RNase H(70) cuts the chemical bond precisely at the junction where the RNA segment meets the DNA segment. This produces a DNA fragment, a polydeoxyribonucleotide, with a phosphate group on one end, and a separate RNA fragment with a hydroxyl group on the other end.

As an abstract-only report of a single enzymatic reaction in a test tube, the study says nothing about how this enzyme behaves in living cells, nor anything about effects in tissue, skin, or whole organisms.

Our reflection

This paper belongs to the foundational era of nucleic-acid enzymology, when researchers were mapping exactly how cells cut, copy and process DNA and RNA at the molecular level. That basic chemistry — understanding what a polydeoxyribonucleotide is and how precisely it can be generated and handled — underpins decades of later work, including today's interest in PDRN as an ingredient. At Havdis, we see papers like this as part of the long scientific lineage the field now builds on.

Source

Karwan R, Wintersberger U (1986). FEBS letters.

Read the paper on PubMedDOI: 10.1016/0014-5793(86)80978-4

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.